Author

Hongqi Tian

Observed name: H Q Tian

Institution: KeChow Pharma (China)

Observed institutions: Central South University, KeChow Pharma (China)

ORCID: 0009-0006-4059-9726

Observed ORCID: 0009-0006-4059-9726

OpenAlex ID: A5086284105

Train's crashworthiness design and collision analysis

2007 · G J Gao, H Q Tian · International Journal of Crashworthiness · 69

Collision performance of square tubes with diaphragms

2014 · Guangjun Gao, Haipeng Dong, et al. · Thin-Walled Structures · 51

Efficacy and Safety of Tunlametinib in Adults with Inoperable Neurofibromatosis Type 1–Associated Plexiform Neurofibromas: Phase IIa Trial and Biomarker Research

2026 · Zhichao Wang, Jingxuan Huang, et al. · Clinical Cancer Research · 3

Data from Efficacy and Safety of Tunlametinib in Adults with Inoperable Neurofibromatosis Type 1–Associated Plexiform Neurofibromas: Phase IIa Trial and Biomarker Research

2026 · Zhichao Wang, Jingxuan Huang, et al.

Supplementary Data 1 from Efficacy and Safety of Tunlametinib in Adults with Inoperable Neurofibromatosis Type 1–Associated Plexiform Neurofibromas: Phase IIa Trial and Biomarker Research

2026 · Zhichao Wang, Jingxuan Huang, et al.

Works count: 5

Citation count: 123

H-index: 3

I10-index: 2